The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies
Open accessAbstract
Background—: Heart valve disease (HVD) is frequent in patients with systemic lupus erythematosus (SLE), and the role of antiphospholipid antibodies (aPL) is controversial. Thus, our objective was to estimate the risk of HVD, including Libman-Sacks endocarditis, associated with aPL in patients with SLE. Methods and Results—: Studies were selected if they investigated the association between aPL and HVD in SLE patients and if aPL-negative patients were included for comparison. Data sources were MEDLINE, Embase, Cochrane Library, hand search, contact with investigators, and reference lists of studies, without language restrictions. Data on study and patient characteristics, risk estimates, and study quality were independently extracted by 2 investigators. Pooled effect estimates were obtained by using the DerSimonian-Laird method. Of 234 identified abstracts, 23 primary studies (15 cross-sectional, 7 cohort, 1 case-control) met inclusion criteria, including 1656 SLE patients and 508 cases of HVD. Compared with SLE patients without aPL (n=988), the overall pooled odds ratios for HVD and Libman-Sacks endocarditis in aPL-positive patients (n=668) were 3.13 (95% confidence interval, 2.31 to 4.24) and 3.51 (95% confidence interval, 1.93 to 6.38), respectively. The risk of HVD depending on aPL subtypes was the highest for lupus anticoagulant at 5.88 (95% confidence interval, 2.92 to 11.84) and IgG anticardiolipin antibodies at 5.63 (95% confidence interval, 3.53 to 8.97). Conclusions—: Overall, the presence of aPL in SLE patients is significantly associated with an increased risk for HVD including Libman-Sacks endocarditis. The risk conferred by IgG anticardiolipin antibodies is as strong as by lupus anticoagulant. Systematic echocardiographic examinations in SLE patients with aPL should be performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Update of the guidelines for lupus anticoagulant detection
PENGO, V., TRIPODI, A., REBER, G., RAND, J. H., ORTEL, T. L., GALLI, M., & DE GROOT, P. G. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03555.x · Cited by 1,197
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
Hojnik, M., George, J., Ziporen, L., & Shoenfeld, Y. (1996) · Circulation · doi:10.1161/01.cir.93.8.1579 · Cited by 443
Wahl, D., Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., & Thibaut, G. (1997) · Lupus · doi:10.1177/096120339700600510 · Cited by 285
Self-citationBrandt, J. T., Barna, L. K., & Triplett, D. A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649988 · Cited by 228
Cited by
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M.-C., Amoura, Z., Andrade, D., Andreoli, L., Artim-Esen, B., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224609 · Cited by 493
Self-citationThe 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M., Amoura, Z., Andrade, D., Andreoli, L., Artim‐Esen, B., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42624 · Cited by 483
Self-citationGuidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
Saric, M., Armour, A. C., Arnaout, M. S., Chaudhry, F. A., Grimm, R. A., Kronzon, I., Landeck, B. F., Maganti, K., Michelena, H. I., & Tolstrup, K. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.09.011 · Cited by 427
The modern epidemiology of heart valve disease
Coffey, S., Cairns, B. J., & Iung, B. (2016) · Heart · doi:10.1136/heartjnl-2014-307020 · Cited by 321
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
Metadata
- Authors
- Zuily, S., Regnault, V., Selton-Suty, C., Eschwège, V., Bruntz, J.-F., Bode-Dotto, E., De Maistre, E., Dotto, P., Perret-Guillaume, C., Lecompte, T., & Wahl, D.
- Venue
- Circulation
- Published
- 2011-07-12
- Volume
- 124
- Issue
- 2
- Pages
- 215-224
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975534632
- Cited by
- 178
- References
- 5
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies. https://app.cochat.ai/papers/10.1161/circulationaha.111.028522
- The paper
- Zuily, S., Regnault, V., Selton-Suty, C., Eschwège, V., Bruntz, J.-F., Bode-Dotto, E., De Maistre, E., Dotto, P., Perret-Guillaume, C., Lecompte, T., & Wahl, D. (2011). Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus: Meta-Analysis of Echocardiographic Studies. Circulation. https://doi.org/10.1161/circulationaha.111.028522
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.